Session information

Tweet

Luncheon Seminar

LS2-9

Current therapeutic issues and future prospects for Acute Myeloid Leukemia.
～New therapeutic strategy with FLT3 inhibitor guilterinib ～

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Nobuhiko Emi (Department of Hematology, Fujita Health University)

Sponsor: Astellas Pharma Inc.

[LS2-9] Current therapeutic issues and future prospects for Acute Myeloid Leukemia.
～New therapeutic strategy with FLT3 inhibitor guilterinib ～

Naoko Hosono (Department of Hematology and Oncology, University of Fukui Hospital)